Byondis B.V.

Byondis and medac Enter Into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine (SYD985)

Nijmegen, Netherlands and Wedel, Germany (ots/PRNewswire) - SYD985 Marketing Authorization Application Soon to Be Submitted to the EMA Byondis B.V., an independent, Dutch clinical stage biopharmaceutical company creating precision medicines, has entered into a License and Collaboration Agreement and a Supply ...